EGX disclosure regarding the upcoming EGM on 17 September 2020 Regulatory DisclosuresBy adminAugust 26, 2020
Details Standalone financial statements for the period ended 30 June 2020Standalone Financial StatementsBy adminAugust 16, 2020
Details Consolidated financial statements for the period ended 30 June 2020Consolidated Financial Statements resultsBy adminAugust 16, 2020
Disclosure to EGX regarding the company’s board composition Regulatory DisclosuresBy adminAugust 5, 2020
Rameda notified of Anviziram, Remdesivir-Rameda vial prices by Egyptian Drug Authority, on track to market first Remdesivir-Rameda production in September 2020 Corporate NewsBy adminJuly 20, 2020
